Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-04-20 00:00:00 ET · period of report 2023-04-18 · accession 0001415889-23-006750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-20 | 2023-04-18 | PTCT | Klein Matthew B. | CEO | A - Grant | $0.00 | +26.0K | 103.9K | +33% | $0 |
| D | 2023-04-20 | 2023-04-18 | PTCT | Klein Matthew B. | CEO | S - Sale | $52.04 | -1,211 | 102.6K | -1% | -$63.0K |
| D | 2023-04-20 | 2023-04-18 | PTCT | Klein Matthew B. | CEO | A - Grant | $0.00 | +65.0K | 65.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-18 | A | A | 26,000 | $0.00 | 103,856 | D | — | — | (F1) Restricted stock units granted on April 18, 2023 that vest in four equal installments over four years, commencing on April 18, 2024. |
| 2 | Common | Common Stock | 2023-04-18 | S | D | 1,211 | $52.04 | 102,645 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-18 | A | A | 65,000 | $0.00 | 65,000 | D | $52.96 · — to 2033-04-17 | 65,000 Common Stock | (F3) This option was granted on April 18, 2023, and vests over four years, with 25% of the shares underlying the option vesting on April 18, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 18, 2024. |